Modified protocol of omalizumab treatment to prevent carboplatin-induced drug hypersensitivity reactions: a case study

Oude Elberink, H. N. G., Jalving, M., Dijkstra, H. & van de Ven, A. A. J. M., 29-Jan-2020, In : Clinical and translational allergy. 10, 1, 5 p., 5.

Research output: Contribution to journalComment/Letter to the editorAcademicpeer-review

Carboplatin administration can usually be safely continued via a so-called desensitisation protocol when hypersensitivity reactions arise. Severe break-through reactions that occur early during desensitisation are likely to be IgE-mediated; in that case, addition of omalizumab premedication should be strongly considered.

Original languageEnglish
Article number5
Number of pages5
JournalClinical and translational allergy
Issue number1
Publication statusPublished - 29-Jan-2020


  • Carboplatin, Desensitisation, Drug hypersensitivity, Omalizumab, DESENSITIZATION, OXALIPLATIN

Download statistics

No data available

ID: 127416369